Susan Catalano, founder and CSO of Cognition Therapeutics, speaks about Cognition’s clinical progress and the underlying rationale for its Alzheimer’s drug program . . .
Cognition Thinks It Has an Alzheimer’s Blockbuster
Source: Vladyslav Bobuskyi/Getty Images
